Galeterone

DB12415InvestigationalSmall molecule

Galeterone has been used in trials studying the treatment of Prostate Cancer.

Mechanism: Pharmacologically active on Androgen receptor and Steroid 17-alpha-hydroxylase/17,20 lyase
Curator reviewed
Formula / weight: C₂₆H₃₂N₂O · 388.5451 g/mol (avg)
Code names: TOK-001 · VN-124 · VN/124-1

Resolves to

Compound

Structure

InChIKeyPAFKTGFSEFKSQG-PAASFTFBSA-NSMILES[H][C@@]12CC=C(N3C=NC4=CC=CC=C34)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C

Targets

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Galeterone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.